437 related articles for article (PubMed ID: 7513917)
21. B cell responses to a peptide epitope. I. The cellular basis for restricted recognition.
Agarwal A; Sarkar S; Nazabal C; Balasundaram G; Rao KV
J Immunol; 1996 Oct; 157(7):2779-88. PubMed ID: 8816380
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
23. Detection of IgM antibodies against coxsackie B viruses by a western blot technique.
del Rosario Zuñiga M; Reichardt J; Braun W; Weber B; Doerr HW
Acta Virol; 1993 Feb; 37(1):1-10. PubMed ID: 8105643
[TBL] [Abstract][Full Text] [Related]
24. Antigenic epitopes of the hepatitis A virus polyprotein.
Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
[TBL] [Abstract][Full Text] [Related]
25. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
Yauch RL; Kim BS
J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
[TBL] [Abstract][Full Text] [Related]
26. [Study on specificity of IgM antibody response in patients with coxsackie virus B infection].
Zhang T; Ma G; Ma L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):66-8. PubMed ID: 12526307
[TBL] [Abstract][Full Text] [Related]
27. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
[TBL] [Abstract][Full Text] [Related]
28. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
29. Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1.
Zhang ZW; Zhang YG; Wang YL; Pan L; Fang YZ; Jiang ST; Lü JL; Zhou P
Vet Microbiol; 2010 Jan; 140(1-2):25-33. PubMed ID: 19699594
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
[TBL] [Abstract][Full Text] [Related]
31. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
32. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
Crainic R; Blondel B; Horaud F
Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856
[TBL] [Abstract][Full Text] [Related]
33. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71.
Zhang J; Dong M; Jiang B; Dai X; Meng J
Virus Res; 2012 Aug; 167(2):337-42. PubMed ID: 22659489
[TBL] [Abstract][Full Text] [Related]
34. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
[TBL] [Abstract][Full Text] [Related]
35. Indirect enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies against Coxsackie B viruses.
Hannington G; Booth JC; Wiblin CN; Stern H
J Med Microbiol; 1983 Nov; 16(4):459-65. PubMed ID: 6315943
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes.
Autran B; Triebel F; Viguier M; Jolivet M; Falmagne P; Debre P
Immunology; 1987 Apr; 60(4):531-8. PubMed ID: 2438207
[TBL] [Abstract][Full Text] [Related]
37. Characterization of antibodies to synthetic nerve growth factor (NGF) and proNGF peptides.
Ebendal T; Persson H; Larhammar D; Lundströmer K; Olson L
J Neurosci Res; 1989 Mar; 22(3):223-40. PubMed ID: 2468788
[TBL] [Abstract][Full Text] [Related]
38. Synthetic peptides for efficient discrimination of anti-enterovirus antibodies at the serotype level.
Routsias JG; Mavrouli MD; Antonaki G; Spanakis N; Tsakris A
Peptides; 2014 Aug; 58():52-9. PubMed ID: 24929043
[TBL] [Abstract][Full Text] [Related]
39. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1.
Pulli T; Roivainen M; Hovi T; Hyypiä T
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735
[TBL] [Abstract][Full Text] [Related]
40. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
